Inward Investment (Hansard, 20 December 1990)

§ Mr. Gareth Wardell
To ask the Secretary of State for Wales if he will list inward investment projects during 1990, specifying the capital investment involved and the number of new jobs created directly.

§ Mr. David Hunt
Between 1 January 1990 arid 30 November 1990, Wales secured 129 inward investment projects involving £484 million of capital investment, promising 7,800 new jobs and safeguarding 7,300 existing jobs. A list of the companies concerned has been placed in the Library of the House though for reasons of commercial confidentiality individual details of investment and jobs are not disclosed.

§ Mr. Gareth Wardell
To ask the Secretary of State for Wales if he will publish in theOfficial Report the additional funding his Department has made to each of the regionally funded renal units in Wales during the current financial year, for the prescribing costs for the drug Erythropoietin; and if he will separately distinguish the number of patients currently receiving such treatment at each unit together with the number of patients refused such treatment because of budgetary constraints on the prescribing consultant.

§ Mr. Nicholas Bennett
Information on the number of patients receiving Erythropoietin is not held centrally. During the current financial year additional funds of £75,000 were made available to each of West Glamorgan and Clwyd health authorities to assist with the prescribing of Erythropoietin at the main renal units within those authorities.

§ Mr. Win Griffiths
To ask the Secretary of State for Wales what representations he has received about the estimated number of patients who would benefit from erythropoietin.

§ Mr. Nicholas Bennett
The use of EPO for individual patients is a matter of clinical judgment at the time. No specific representations have been received about the aggregate number of patients who might benefit from its use. Managing health authorities of main renal dialysis units receive central revenue support which includes the cost of drugs at estimated levels of need.

§ Mr. Win Griffiths
To ask the Secretary of State for Wales whether he has received, and intends to acquire, information from district health authorities on the extent to which the funding provided for the 1991–92 financial year will meet the needs of all patients who fulfil the criteria for benefiting from erythropoietin.

§ Mr. Nicholas Bennett
Following the dedesignation of regional services from 1991–92 it will be for district health258W authorities to determine the resources which should be made available for the prescription of drugs, including erythropoietin.